270 related articles for article (PubMed ID: 12225876)
1. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
[TBL] [Abstract][Full Text] [Related]
2. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
3. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
4. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
[TBL] [Abstract][Full Text] [Related]
6. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA
J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
9. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
10. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
12. Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
Luk C; Giovannoni G; Williams DR; Lees AJ; de Silva R
J Neurosci Methods; 2009 May; 180(1):34-42. PubMed ID: 19427527
[TBL] [Abstract][Full Text] [Related]
13. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
[TBL] [Abstract][Full Text] [Related]
14. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
[TBL] [Abstract][Full Text] [Related]
15. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
Uchihara T; Hara M; Nakamura A; Hirokawa K
Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.
Chambers CB; Lee JM; Troncoso JC; Reich S; Muma NA
Ann Neurol; 1999 Sep; 46(3):325-32. PubMed ID: 10482263
[TBL] [Abstract][Full Text] [Related]
20. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
